Rare Bleeding Disorders
Congress materials
View posters, abstracts and other materials about rare bleeding disorders presented at recent congresses.
Some content may have changed since publication. Some links may require registration/login to access the content. Any attached publications and/or any tables or figured derived from the publications are copyright-protected works. Novo Nordisk has obtained permission from the copyright owner to use this work on this site. You may not reproduce, prepare derivative works from, display or distribute this work unless you obtain the permission of the copyright owner, or as otherwise may be permitted by law.
We didn't find any resources that match your selection.
Please adjust your filter(s) and try again.
ASH Abstracts 2024
European Hematology Association (EHA) Materials
View posters and presentations from the EHA 2024 virtual conference on the Novo Nordisk Science Hub.
International Society on Thrombosis and Haemostasis (ISTH)
View posters and presentations from the ISTH 2021 virtual conference on the Novo Nordisk Science Hub.
American Society of Haematology (ASH) Materials
View posters and presentations from the ASH 2023 conference on the Novo Nordisk Science Hub.
Find more information
Find product information
Explore our portfolio of products for treating rare bleeding disorders, including prescribing information, safety data sheets and storage and stability information.
Continuing education
Explore accredited rare bleeding disorders education opportunities supported by Novo Nordisk and provided by third-party organizations.
The purpose of this site is to provide relevant medical and scientific information about Novo Nordisk products and areas of therapeutic interest. Information about investigational products or investigational uses of approved products neither implies FDA approval for these products or uses, nor establishes the safety or efficacy of these products or uses. There is no guarantee that any investigational product or investigational use will receive FDA approval or become commercially available in the United States. Novo Nordisk does not recommend or suggest use of its products in any manner inconsistent with FDA-approved labeling.
This site is intended for United States healthcare professionals only. The information on this site—including all product information—pertains to residents of the United States only. Any products referenced on this site may have different labelling in different countries.
